U.S. federal trademark · Serial No. 86566524 · Reg. No. 5891462
Providing medical testing services in the field of cancer research and disease classification, namely, monitoring and predicting disease and risk of disease, identifying risk factors of disease, prognostic testing, gene and/or protein testing and identifying physiological characteristics, particularly as each relates to breast disease including breast cancer
Kits comprising blood drawing apparatus and molecular biological reagents useful for detecting gene expression products, namely, ribonucleic acid (RNA), copy deoxyribonucleotic acids (cDNA), polymerase chain reaction (PCR) products or proteins, as an indication of body state, namely, body health, condition, disease or response to therapeutic treatment, particularly with regard to breast disease and including breast cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.